Trial Profile
Procalcitonin levels as predictive marker of remission during treatment with tocilizumab in biologic-naive patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 10 Dec 2015 New trial record